Truncated plakophilin-2 (581-590)

Truncated plakophilin-2 (581-590) is a synthetic peptide fragment derived from the C-terminal region of plakophilin-2, a critical armadillo-repeat protein involved in the formation and stabilization of desmosomal cell-cell junctions. As a component of the plakophilin family, this specific peptide sequence encompasses residues 581 to 590, representing a functionally relevant domain frequently investigated for its role in mediating protein-protein interactions within cardiac and epithelial tissues. Its defined structure and biochemical properties make it a valuable molecular tool for elucidating the mechanisms of desmosomal assembly, signaling, and the broader implications of plakophilin-2 in cellular adhesion and communication.

Protein-protein interaction studies: Researchers utilize the truncated plakophilin-2 (581-590) peptide as a probe to dissect the specific binding interfaces between plakophilin-2 and its interaction partners. By introducing this peptide into in vitro binding assays, it becomes possible to map the minimal sequences required for association with desmosomal cadherins, desmoplakin, or other cytoplasmic proteins. This approach aids in clarifying the molecular determinants of desmosome organization, offering insight into the structural underpinnings of cell junction stability and the consequences of plakophilin-2 mutations.

Peptide competition assays: The defined sequence of this fragment is ideally suited for competitive inhibition experiments. In these assays, the peptide is used to disrupt native protein-protein interactions by mimicking the corresponding domain of the full-length protein. This strategy enables researchers to evaluate the functional contribution of the 581-590 region to overall plakophilin-2 activity and to assess the consequences of blocking this interface on desmosomal assembly, cellular adhesion, or downstream signaling pathways.

Antibody epitope mapping: The truncated peptide serves as a well-characterized antigen for the generation and validation of site-specific antibodies against plakophilin-2. By employing the 581-590 fragment in immunization protocols or as a target in epitope mapping assays, investigators can develop antibodies with high specificity for this region. Such antibodies are valuable tools for immunoblotting, immunoprecipitation, and immunofluorescence applications, enabling the precise detection and localization of plakophilin-2 in cellular and tissue samples.

Structure-function analysis: The synthetic nature and defined sequence of the peptide allow for detailed structure-function studies, including conformational analyses and mutagenesis experiments. Researchers can investigate how alterations within this fragment influence its secondary structure, binding affinity, or ability to mediate intermolecular interactions. These findings contribute to a deeper understanding of plakophilin-2's modular architecture and the specific contributions of its C-terminal domains to desmosomal integrity.

Biochemical assay development: The availability of a pure, sequence-defined peptide corresponding to plakophilin-2's 581-590 region supports the design of robust biochemical assays for screening molecular inhibitors, studying post-translational modifications, or assessing peptide-mediated signaling events. Such assays facilitate the identification of compounds or conditions that modulate plakophilin-2 function, thereby advancing research into the regulation of cell-cell adhesion and the pathogenesis of desmosome-related disorders.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling